InvestorsHub Logo

help me

08/15/22 5:18 PM

#13586 RE: resx18 #13585

LOI are meaningless. This company has so many LOIs they announced and have never came true.

bow wow get the pet tracker lol


Harold

Cameo Brien

08/15/22 6:04 PM

#13590 RE: resx18 #13585

Boom
“We believe this proposed relationship with GTX can improve our go to market efforts for our qTerm device particularly as it is our first fully developed commercial release. GTX’s proven extensive global reach, experience in getting innovative products to market, and deep understanding of our technologies, were critical factors in our decision to enter into this letter of intent, which potentially may lead into a formal license agreement.” stated the Company’s Chief Technology Officer, Danny Rittman

Anita Dump

08/15/22 6:07 PM

#13591 RE: resx18 #13585

HUGE NEWS The second LOI establishes a mutual path to evaluate the viability and market size of the Company’s Intellectual Property (IP) with the goal of the parties to enter a worldwide exclusive licensing agreement for GTX to manufacture, sell and distribute GBT’s products. The main focus is aimed on the qTerm – an AI driven, human vital sign device (https://qterm.me).

Cameo Brien

08/16/22 1:02 PM

#13665 RE: resx18 #13585

Lets go!

$GTCH and $GTXO enter into 2nd LOI !!

GBT Technologies and GTX Corp Enter into a Second Letter of Intent Covering the Potential Worldwide Licensing rights for the Manufacturing, Sales and Distribution Focusing on qTerm

Anita Dump

08/17/22 9:16 PM

#13737 RE: resx18 #13585

GBT Technologies Inc. (OTC: GTCH) (the “Company”), a technology company focused on developing a portfolio of Intellectual Property targeted on integrated circuits design automation, IoT (Internet of Things), mesh radio technology and Artificial Intelligence (AI), today announced that on August 1, 2022, the Company and GTX Corp (OTC: GTXO) (“GTX”), a pioneer in the fields of health & safety GPS wearables, human & asset tracking systems, and personal protective medical equipment supplies, entered into a second Letter of Intent (“LOI”) (the initial LOI was signed on June 10, 2021). The second LOI establishes a mutual path to evaluate the viability and market size of the Company’s Intellectual Property (IP) with the goal of the parties to enter a worldwide exclusive licensing agreement for GTX to manufacture, sell and distribute GBT’s products. The main focus is aimed on the qTerm – an AI driven, human vital sign device (https://qterm.me).